Investor mix
10 investors on record; lead investors include Syncona, Novo Holdings, Eventide Asset Management, Wellington.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 40% |
| Private equity | 2 | 20% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 3 | 30% |
Developer of gene therapies for debilitating chronic diseases
10 investors on record; lead investors include Syncona, Novo Holdings, Eventide Asset Management, Wellington.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 40% |
| Private equity | 2 | 20% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 3 | 30% |